Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Krailo

Showing results (11-20 of 161) with videos related to

Pageof 17
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Reply to G. Mangili et al and C. Lhommé et alDeborah F Billmire, Mark Krailo, Carlos Rodriguez-Galindo, et al.
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Treatment of hepatoblastoma: the North American cooperative group experienceMarcio H Malogolowkin, Howard M Katzenstein, Mark Krailo, et al.
Pediatric Blood & Cancer|October 16, 2013
Response to "High BMI at diagnosis is associated with inferior survival in patients with osteosarcoma"Sadaf Altaf, Felicity Enders, Mark Krailo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plansAlberto S Pappo, Mark Krailo, Zhengjia Chen, et al.
Pediatric Blood & Cancer|May 25, 2013
Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG)Marcio H Malogolowkin, Mark Krailo, Neyssa Marina, et al.
Pediatric Blood & Cancer|April 12, 2012
"Accelerated ear-age": a new measure of chemotherapy-induced ototoxicityBrian J Fligor, Jennie D Krasker, Doojduen Villaluna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology GroupMary Johansen, John Kuttesch, W Archie Bleyer, et al.
Journal of Pediatric Surgery|December 18, 2007
Surgical resection of pulmonary metastatic lesions in children with hepatoblastomaRebecka L Meyers, Howard M Katzenstein, Mark Krailo, et al.
Journal of Exposure Science & Environmental Epidemiology|March 9, 2017
Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children's Oncology GroupAmanda E Janitz, Gurumurthy Ramachandran, Gail E Tomlinson, et al.
British Journal of Cancer|October 25, 2017
Family history of cancer in children and adolescents with germ cell tumours: a report from the Children's Oncology GroupJenny N Poynter, Michaela Richardson, Michelle Roesler, et al.
Pageof 17

Showing results (11-20 of 161) with videos related to

Sort By:
Pageof 17
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Reply to G. Mangili et al and C. Lhommé et alDeborah F Billmire, Mark Krailo, Carlos Rodriguez-Galindo, et al.
Frontiers in Bioscience (Elite Edition)|December 29, 2011
Treatment of hepatoblastoma: the North American cooperative group experienceMarcio H Malogolowkin, Howard M Katzenstein, Mark Krailo, et al.
Pediatric Blood & Cancer|October 16, 2013
Response to "High BMI at diagnosis is associated with inferior survival in patients with osteosarcoma"Sadaf Altaf, Felicity Enders, Mark Krailo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2010
Infrequent tumor initiative of the Children's Oncology Group: initial lessons learned and their impact on future plansAlberto S Pappo, Mark Krailo, Zhengjia Chen, et al.
Pediatric Blood & Cancer|May 25, 2013
Pilot study of cisplatin, etoposide, bleomycin, and escalating dose cyclophosphamide therapy for children with high risk germ cell tumors: a report of the children's oncology group (COG)Marcio H Malogolowkin, Mark Krailo, Neyssa Marina, et al.
Pediatric Blood & Cancer|April 12, 2012
"Accelerated ear-age": a new measure of chemotherapy-induced ototoxicityBrian J Fligor, Jennie D Krasker, Doojduen Villaluna, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 24, 2006
Phase I evaluation of oral and intravenous vinorelbine in pediatric cancer patients: a report from the Children's Oncology GroupMary Johansen, John Kuttesch, W Archie Bleyer, et al.
Journal of Pediatric Surgery|December 18, 2007
Surgical resection of pulmonary metastatic lesions in children with hepatoblastomaRebecka L Meyers, Howard M Katzenstein, Mark Krailo, et al.
Journal of Exposure Science & Environmental Epidemiology|March 9, 2017
Maternal and paternal occupational exposures and hepatoblastoma: results from the HOPE study through the Children's Oncology GroupAmanda E Janitz, Gurumurthy Ramachandran, Gail E Tomlinson, et al.
British Journal of Cancer|October 25, 2017
Family history of cancer in children and adolescents with germ cell tumours: a report from the Children's Oncology GroupJenny N Poynter, Michaela Richardson, Michelle Roesler, et al.
Pageof 17